BUY Alivus Life Sciences Limited — Siddharth Rai Mangala
bySiddharth Rai MangalaHorizon: NA (inferred Swing (≤2wk))9 Sept 2026via Zee Business (Live)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Alivus Life Sciences passes ₹5 dividend, approves FY26 results at AGM
NewsGoogle News·8 Sept · 6d ago
1 advisor has an active short-term BUY call on this stock
Advisor consensus · adjacent horizon·30 Jun · 3mo ago
Nothing found in this tip’s window yet.
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Alivus Life Sciences
- BUY — Shrikant Chouhan, Kotak Securities30 Jun 2026 · ~3 months · target ₹1,315 · Target hit
- BUY — ICICI Securities15 May 2026 · ~1 year · target ₹1,235 · Target hit
- BUY — ICICI Securities23 Jan 2026 · ~1 year · target ₹1,190 · Target hit
- BUY — ICICI Securities7 Nov 2025 · ~1 year · target ₹1,180 · Target hit
- BUY — ICICI Securities26 Aug 2024 · ~1 year · target ₹1,295 · Target hit
More from Siddharth Rai Mangala
- BUY Gillette India23 Oct 2026 · ~1 year · target ₹8,200 · Active
- BUY SAGILITY23 Oct 2026 · ~2 weeks · target ₹48 · SL hit
- BUY Godrej Agrovet23 Oct 2026 · ~2 weeks · target ₹655 · SL hit
- BUY Balkrishna Industries23 Oct 2026 · Same day · target ₹2,145 · SL hit
- BUY Federal Bank22 Oct 2026 · ~2 weeks · target ₹365 · SL hit

